ASTELLAS PHARMA

🇯🇵Japan

Country: 🇯🇵Japan

Ownership: -

Established: 2005-01-01

Employees: -

Market Cap: $22.5B

Website: https://www.astellas.com/

Clinical Trials

Long-Term Specified Drug Use-Results Survey for Xtandi Capsule

Completed

Conditions: Castration-resistant Prostate Cancer

Interventions: Drug: enzalutamide

First Posted Date: 2016-02-01

Last Posted Date: 2024-11-21

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 1018

Registration Number: NCT02669771

Reproducibility Study of OABSS and Its Response to Treatment

Phase 4

Completed

Conditions: Overactive Bladder

Interventions: Drug: Solifenacin

First Posted Date: 2016-01-29

Last Posted Date: 2016-01-29

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 50

Registration Number: NCT02667470

Locations: 🇹🇭
Site: 1, Bangkok, Thailand

Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients

Phase 3

Completed

Conditions: Restless Legs Syndrome

Interventions: Drug: ASP8825

First Posted Date: 2016-01-18

Last Posted Date: 2016-02-04

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 182

Registration Number: NCT02658188

A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)

Phase 4

Completed

Conditions: Overactive Bladder

Interventions: Drug: Placebo
Drug: Mirabegron
Drug: Tamsulosin

First Posted Date: 2016-01-14

Last Posted Date: 2024-11-11

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 568

Registration Number: NCT02656173

Locations: 🇯🇵
Site JP81043, Fukuoka, Japan
🇯🇵
Site JP81048, Fukuoka, Japan
🇯🇵
Site JP81003, Hokkaido, Japan

and more 55 locations

ASP8825 - A Study to Investigate the Food Effect on the Pharmacokinetics of ASP8825

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: ASP8825

First Posted Date: 2015-12-16

Last Posted Date: 2015-12-16

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 18

Registration Number: NCT02632331

ASP8825 - Pharmacokinetics Study in Patients With Impaired Renal Function and Haemodialysis

Phase 1

Completed

Conditions: Patients With Impaired Renal Function and Haemodialysis

Interventions: Drug: ASP8825

First Posted Date: 2015-12-14

Last Posted Date: 2016-02-04

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 18

Registration Number: NCT02629224

Special Drug Use Surveillance of Irribow in Female Patients

Completed

Conditions: Diarrhea-predominant Irritable Bowel Syndrome

Interventions: Drug: Ramosetron

First Posted Date: 2015-11-24

Last Posted Date: 2024-10-21

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 793

Registration Number: NCT02612649

Pharmacokinetics Study in Patients With Impaired Renal Function and Subjects With Normal Renal Function

Phase 1

Completed

Conditions: Patients With Impaired Renal Function

Interventions: Drug: ASP015K

First Posted Date: 2015-11-11

Last Posted Date: 2024-10-16

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 31

Registration Number: NCT02603497

Locations: 🇯🇵
Site JP00002, Tokyo, Japan
🇯🇵
Site JP00001, Tokyo, Japan

Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870

Phase 3

Completed

Conditions: Active Rheumatoid Arthritis

Interventions: Drug: CDP870

First Posted Date: 2015-10-26

Last Posted Date: 2015-11-16

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 86

Registration Number: NCT02586246

Pharmacokinetics Study in Patients With Impaired Hepatic Function

Phase 1

Completed

Conditions: Patients With Impaired Hepatic Function

Interventions: Drug: ASP015K

First Posted Date: 2015-10-26

Last Posted Date: 2024-10-16

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 24

Registration Number: NCT02586194

Locations: 🇯🇵
Site JP00004, Tokyo, Japan
🇯🇵
Site JP00003, Kanagawa, Japan
🇯🇵
Site JP00001, Fukuoka, Japan

and more 3 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy